BDBM50261906 3-(4-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)quinoline::CHEMBL467391

SMILES Clc1ccc(cc1)-c1noc(n1)C1CCN(CC1)c1cnc2ccccc2c1

InChI Key InChIKey=ZGRXRDVVSAPZEB-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50261906   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50261906(3-(4-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)pipe...)
Affinity DataEC50:  1.78E+3nMAssay Description:Agonist activity at human CB2 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50261906(3-(4-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)pipe...)
Affinity DataEC50:  2.62E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed